US 12,226,331 B2
Apparatus for treating obesity
Peter Forsell, Bouveret (CH)
Filed by Peter Forsell, Bouveret (CH)
Filed on Oct. 24, 2022, as Appl. No. 17/971,702.
Application 17/971,702 is a continuation of application No. 16/882,563, filed on May 25, 2020, granted, now 11,523,892.
Application 16/882,563 is a continuation of application No. 15/425,568, filed on Feb. 6, 2017, granted, now 10,660,777, issued on May 26, 2020.
Application 15/425,568 is a continuation of application No. 13/123,014, granted, now 9,561,033, issued on Feb. 7, 2017, previously published as PCT/SE2009/051156, filed on Oct. 12, 2009.
Claims priority of provisional application 61/213,813, filed on Jul. 17, 2009.
Claims priority of application No. 0802138 (SE), filed on Oct. 10, 2008; application No. PCT/SE2009/000047 (WO), filed on Jan. 29, 2009; application No. PCT/SE2009/000048 (WO), filed on Jan. 29, 2009; and application No. 0901007 (SE), filed on Jul. 17, 2009.
Prior Publication US 2023/0046613 A1, Feb. 16, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61F 5/00 (2006.01); A61B 17/00 (2006.01); A61B 17/068 (2006.01); A61B 17/08 (2006.01); A61B 17/34 (2006.01); A61N 1/36 (2006.01); A61B 1/04 (2006.01); A61B 1/06 (2006.01); A61B 1/273 (2006.01); A61B 1/313 (2006.01); A61B 17/04 (2006.01); A61B 17/064 (2006.01); A61B 17/30 (2006.01); A61B 17/32 (2006.01); A61F 2/04 (2013.01)
CPC A61F 5/003 (2013.01) [A61B 17/00 (2013.01); A61B 17/00234 (2013.01); A61B 17/068 (2013.01); A61B 17/08 (2013.01); A61F 5/0003 (2013.01); A61F 5/0013 (2013.01); A61F 5/005 (2013.01); A61F 5/0069 (2013.01); A61F 5/0073 (2013.01); A61F 5/0079 (2013.01); A61F 5/0086 (2013.01); A61F 5/0089 (2013.01); A61N 1/36007 (2013.01); A61B 1/04 (2013.01); A61B 1/06 (2013.01); A61B 1/2736 (2013.01); A61B 1/3132 (2013.01); A61B 2017/00278 (2013.01); A61B 2017/00561 (2013.01); A61B 2017/00818 (2013.01); A61B 2017/00827 (2013.01); A61B 17/0469 (2013.01); A61B 17/064 (2013.01); A61B 17/0682 (2013.01); A61B 2017/081 (2013.01); A61B 17/30 (2013.01); A61B 2017/306 (2013.01); A61B 2017/308 (2013.01); A61B 17/320016 (2013.01); A61B 17/3423 (2013.01); A61B 17/3474 (2013.01); A61F 2/04 (2013.01); A61F 2002/044 (2013.01); A61F 2002/045 (2013.01); A61F 2005/0016 (2013.01); A61F 2005/002 (2013.01); A61F 2005/0023 (2013.01); A61F 5/0026 (2013.01); A61F 5/0033 (2013.01); A61F 5/0036 (2013.01); A61F 5/004 (2013.01); A61F 5/0043 (2013.01); A61F 5/0046 (2013.01); A61F 5/0063 (2013.01); A61F 5/0076 (2013.01); A61F 2250/0001 (2013.01); A61F 2250/0004 (2013.01)] 14 Claims
OG exemplary drawing
 
1. A method for treating obesity in a patient having a stomach with a food cavity by implanting a volume filling device that, when implanted in a patient, reduces said food cavity in size by a volume substantially exceeding the volume of said volume filling device, the volume filling device comprising a first volume filling device segment and a second volume filling device segment being configured to be assembled into the volume filling device, the method comprising the steps of:
cutting the skin of the patient's abdomen;
dissecting an area of the stomach;
assembling the first volume filling device segment and the second volume filling device segment to form the volume filling device;
introducing the assembled volume filling device into the abdominal cavity;
placing the assembled volume filling device on the stomach wall; and
at least partly invaginating the assembled volume filling device in the stomach wall by providing stomach to stomach sutures or staples to the stomach wall, thereby positioning the assembled volume filling device so that the volume of the food cavity is reduced in size by a volume substantially exceeding the volume of the assembled volume filling device.